CAS 906093-29-6

3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide (2:5)

Description:

3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide (2:5), with CAS number 906093-29-6, is a complex organic compound characterized by its thiazolidine core structure, which is a five-membered ring containing sulfur and nitrogen atoms. This compound features multiple functional groups, including a piperazine moiety and a pyrrolidine ring, contributing to its potential biological activity. The presence of a pyrazole ring suggests possible interactions with various biological targets, making it of interest in medicinal chemistry. The hydrobromide salt form indicates enhanced solubility in aqueous environments, which is beneficial for pharmacological applications. Its stereochemistry, particularly the (2S,4S) configuration, may influence its biological activity and interaction with receptors or enzymes. Overall, this compound's unique structural features and functional groups position it as a candidate for further research in drug development, particularly in areas related to neuropharmacology or other therapeutic fields.

Synonyms:

• Teneligliptin Hydrobromide

Teneligliptin hydrobromide

CAS: 906093-29-6

Teneligliptin hydrobromide

Purity: ≥95%

Molecular weight: 628.86g/mol

Ref: 54-BUP13365

Bis(((2S,4S)-4-(4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-Yl)Piperazin-1-Yl)Pyrrolidin-2-Yl)(Thiazolidin-3-Yl)Methanone) Pentahydrobromide

CAS: 906093-29-6

Bis(((2S,4S)-4-(4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-Yl)Piperazin-1-Yl)Pyrrolidin-2-Yl)(Thiazolidin-3-Yl)Methanone) Pentahydrobromide

Purity: 98%

Molecular weight: 1257.72g/mol

Ref: 54-OR1026682

Teneligliptin HBr

CAS: 906093-29-6

Formula: C₂₂H₃₀N₆OS·5HBr

Color and Shape: White To Off-White Solid

Molecular weight: 426.59 2.5*80.91

Ref: 4Z-T-145001

Teneligliptin hydrobromide

CAS: 906093-29-6

Teneligliptin hydrobromide: potent, novel DPP-4 inhibitor; inhibits human/rat plasma DPP-4 with ~1 nM IC50.

Formula: C₂₂H₃₀N₆OSBrH

Purity: 97.83% - 99.92%

Color and Shape: Solid

Molecular weight: 628.86

Ref: TM-T6999

Teneligliptin Hydrobromide (2:5)

Controlled Product

CAS: 906093-29-6

Applications Teneligliptin Hydrobromide (2:5) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion, and has a half-life of 24.2 hours in the human body.
References Goda, M. & Kadowaki, T.: Drugs Today, 49, 615 (2013); Kishimoto, M.: Diabetes Metab. Syndr. Obes., 6, 187 (2012)

Formula: C₂₂H₃₂·5Br₂·5N₆OS

Color and Shape: Neat

Molecular weight: 628.86

Ref: TR-T018300

3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide

CAS: 906093-29-6

Canagliflozin is a pharmaceutical drug that is used to treat type 2 diabetes. It is an oral medication that works by blocking the absorption of glucose in the intestine, which lowers blood sugar levels and improves insulin sensitivity. Canagliflozin has been shown to have a number of effects on metabolism, including increased bile acid production and decreased fat absorption. This drug also has a number of side effects, including diarrhea, nausea, and vomiting. Canagliflozin is used in combination with metformin or insulin for the treatment of type 2 diabetes. The drug's most common side effect is diarrhea, which can be managed by eating more fiber-rich foods and drinking plenty of fluids.

Formula: (C₂₂H₃₀N₆OS)₂•(HBr)₅

Purity: Min. 95%

Color and Shape: White/Off-White Solid

Molecular weight: 1,257.72 g/mol

Ref: 3D-FM61598